About the VHIR
Here at the Vall d'Hebron Research Institute (VHIR) we promote biomedical research, innovation and teaching. Over 1,800 people are seeking to understand diseases today so the treatment can be improved tomorrow.
Research
We are working to understand diseases, to find out how they operate and to create better treatments for patients. Get to know about our groups and their lines of research.
People
People are the centre of the Vall d'Hebron Research Institute (VHIR). This is why we are bound by the principles of freedom of research, gender equality and professional attitudes that HRS4R promotes.
Clinical trials
Our work is not just basic or translational; we are leaders in clinical research. Enter and find about the clinical trials we are conducting and why we are a world reference in this field.
Progress
Our aim is to make the research carried out at the Vall d’Hebron Research Institute (VHIR) a driving force for transformation. How? By identifying new channels and solutions for the promotion of people's health and well-being.
Core facilities
We offer specialist support for researchers, internal and external alike, ranging from specific services to preparing complete projects. All this, from a perspective of quality and speed of response.
News
We offer you a gateway for staying up to date on everything going on at the Vall d’Hebron Research Institute (VHIR), from the latest news to future solidarity activities and initiatives that we are organising.
Our group aims to unravel the molecular mechanisms of cancer progression and metastasis to identify new diagnostic, prognostic and therapeutic targets in cancer. By combining the knowledge and availability of human tumors in the Pathology department with the expertise of the basic molecular cell biology research group, we focus on:
PMID: 33420574 Journal: SKELETAL RADIOLOGY Year: 2021 Reference: Skeletal Radiol. 2021 Jun;50(6):1263-1270. doi: 10.1007/s00256-020-03687-3. Epub 2021 Jan 8. Impact factor: 2.199 Publication type: Letter or abstract Authors: Marton, Nikolett, Ramos-Oliver, Irma, Cajal, Alfredo Gimeno, de Albert, Matias, Dominguez Oronoz, Rosa et al. DOI: 10.1007/s00256-020-03687-3
PMID: 33406589 Journal: Journal of Clinical Medicine Year: 2021 Reference: J Clin Med. 2021 Jan 4;10(1). pii: jcm10010141. doi: 10.3390/jcm10010141. Impact factor: 4.242 Publication type: Paper in international publication Authors: Chamoun, Betty, Torres, Irina B, Gabaldon, Alejandra, Sellares, Joana, Perello, Manel, Castella, Eva, Guri, Xavier, Salcedo, Maite, Toapanta, Nestor G, Cidraque, Ignacio et al. DOI: 10.3390/jcm10010141
PMID: 33397968 Journal: npj Breast Cancer Year: 2021 Reference: NPJ Breast Cancer. 2021 Jan 4;7(1):1. doi: 10.1038/s41523-020-00208-2. Impact factor: 6.923 Publication type: Paper in international publication Authors: Lluch, Ana, Chic, Nuria, Braso-Maristany, Fara, Pare, Laia, Pascual, Tomas, Conte, Benedetta, Martinez-Saez, Olga, Adamo, Barbara, Vidal, Maria, Barnadas, Esther et al. DOI: 10.1038/s41523-020-00208-2
On World Cancer Research Day, we highlight the oncology research model of the Vall d'Hebron Campus that allows laboratory results to be transferred as quickly as possible to clinical practice.
Vall d’Hebron ha celebrat avui la Jornada del Dia Mundial contra el Càncer, una malaltia cada cop més freqüent que patiran al llarg de la vida un de cada dos homes i una de cada tres dones del nostre entorn.
The multidisciplinary paper on papillary thyroid cancer has been considered the best original article of 2021 in the journal Endocrinología, Diabetes y Nutrición
Check the current rates for the services offered by the Translational Molecular Pathology research group.
Current Rates
PDF 0.22 MB
Rates 2016-2020
PDF 0.18 MB
